We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.83B
AUM Growth
+$108M
(+2.3%)
Cap. Flow
+$83.9M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
12.94%
Holding
1,335
New
249
Increased
372
Reduced
442
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$35.5M |
| 2 |
CVS Health
CVS
|
+$32.5M |
| 3 |
Biogen
BIIB
|
+$24.9M |
| 4 |
Citigroup
C
|
+$23.8M |
| 5 |
PAY
Verifone Systems Inc
PAY
|
+$21.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Targa Resources
TRGP
|
+$31.7M |
| 2 |
Comcast
CMCSA
|
+$23.5M |
| 3 |
Verizon
VZ
|
+$23.2M |
| 4 |
Amazon
AMZN
|
+$22.2M |
| 5 |
Eli Lilly
LLY
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Financials | 15.76% |
| 3 | Healthcare | 13.7% |
| 4 | Industrials | 10.3% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
676
DELISTED
Revance Therapeutics, Inc.
RVNC
| $699K | 0.01% |
51,400
-31,490
| -38% | -$557K |
|
677
NewMarket
NEU
$7.17B
| $682K | 0.01% |
1,647
| – | – |
|
678
American Superconductor
AMSC
$1.48B
| $675K | 0.01% |
79,951
+24,491
| +44% | +$228K |
|
|
CCXI
679
DELISTED
ChemoCentryx, Inc.
CCXI
| $675K | 0.01% |
150,321
+5,008
| +3% | +$18.8K |
|
|
IBTX
680
DELISTED
Independent Bank Group, Inc.
IBTX
| $675K | 0.01% |
15,720
+4,340
| +38% | +$155K |
|
|
ESIO
681
DELISTED
Electro Scientific Industries
ESIO
| $674K | 0.01% |
115,461
+54,223
| +89% | +$371K |
|
682
AAR Corp
AIR
$5.15B
| $672K | 0.01% |
28,809
+19,409
| +206% | +$461K |
|
|
INVX
683
Innovex International
INVX
$1.87B
| $672K | 0.01% |
11,500
-21,160
| -65% | -$1.28M |
|
|
BGG
684
DELISTED
Briggs & Stratton Corp.
BGG
| $669K | 0.01% |
+31,600
| New | +$683K |
|
|
WNR
685
DELISTED
Western Refining Inc
WNR
| $666K | 0.01% |
32,300
-75,610
| -70% | -$1.78M |
|
686
Daktronics
DAKT
$941M
| $665K | 0.01% |
+106,400
| New | +$802K |
|
|
ACAT
687
DELISTED
Arctic Cat Inc
ACAT
| $665K | 0.01% |
39,140
| – | – |
|
688
Comtech Telecommunications
CMTL
$51.8M
| $660K | 0.01% |
+51,400
| New | +$1.08M |
|
|
STRZA
689
DELISTED
Starz - Series A
STRZA
| $647K | 0.01% |
21,630
+8,330
| +63% | +$222K |
|
690
LyondellBasell Industries
LYB
$19.5B
| $636K | 0.01% |
+8,540
| New | +$705K |
|
691
Rogers Corp
ROG
$2.33B
| $629K | 0.01% |
+10,300
| New | +$634K |
|
692
Delek US
DK
$3.87B
| $627K | 0.01% |
47,480
-10,005
| -17% | -$142K |
|
|
CRR
693
DELISTED
Carbo Ceramics Inc.
CRR
| $625K | 0.01% |
47,700
+9,100
| +24% | +$123K |
|
694
Cohu
COHU
$2.39B
| $622K | 0.01% |
57,358
-2,686
| -4% | -$30.9K |
|
|
XYZ
695
Block Inc
XYZ
$45.9B
| $622K | 0.01% |
68,700
+22,600
| +49% | +$256K |
|
696
Alkermes
ALKS
$8.82B
| $621K | 0.01% |
14,363
-245,268
| -94% | -$10.1M |
|
697
Liquidity Services
LQDT
$1.17B
| $619K | 0.01% |
78,993
+1,400
| +2% | +$8.84K |
|
698
BancFirst
BANF
$3.92B
| $616K | 0.01% |
20,432
+400
| +2% | +$12.1K |
|
699
Tanger
SKT
$4.82B
| $615K | 0.01% |
15,309
| – | – |
|
|
TCF
700
DELISTED
TCF Financial Corporation Common Stock
TCF
| $612K | 0.01% |
16,420
-5,400
| -25% | -$205K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2016 Portfolio in Review
As of Q2 2016, Jacobs Levy Equity Management held 1,335 positions worth $4.83B, up 2.3% from $4.72B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2016 filing shows 249 new, 372 increased, 442 reduced and 194 closed positions. Its largest new stake was CVS Health: 325,716 shares worth $31.2M. The largest sale was Targa Resources, an estimated $31.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q2 2016 buy was CVS Health: 325,716 shares worth $31.2M.
- Jacobs Levy Equity Management added most to Microsoft in Q2 2016, an estimated $35.5M increase.
- Jacobs Levy Equity Management's biggest Q2 2016 reduction was Comcast, cutting an estimated $23.5M.
- Jacobs Levy Equity Management fully exited Targa Resources in Q2 2016, selling an estimated $31.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.83B portfolio in Q2 2016.
- Jacobs Levy Equity Management opened 249 new positions and closed 194 in Q2 2016.
- Jacobs Levy Equity Management's portfolio value rose 2.3% quarter-over-quarter to $4.83B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.